1. Home
  2. PTCT vs IEP Comparison

PTCT vs IEP Comparison

Compare PTCT & IEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$72.06

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Logo Icahn Enterprises L.P.

IEP

Icahn Enterprises L.P.

HOLD

Current Price

$7.52

Market Cap

5.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
IEP
Founded
1998
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.0B
IPO Year
2006
1994

Fundamental Metrics

Financial Performance
Metric
PTCT
IEP
Price
$72.06
$7.52
Analyst Decision
Buy
Analyst Count
17
0
Target Price
$80.65
N/A
AVG Volume (30 Days)
1.2M
843.3K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
24.39%
EPS Growth
264.48
N/A
EPS
0.90
N/A
Revenue
$264,734,000.00
$9,658,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$17.70
$5.02
P/E Ratio
$80.71
N/A
Revenue Growth
36.19
N/A
52 Week Low
$47.94
$7.08
52 Week High
$90.87
$9.52

Technical Indicators

Market Signals
Indicator
PTCT
IEP
Relative Strength Index (RSI) 42.24 48.40
Support Level $68.16 $7.17
Resistance Level $72.09 $7.80
Average True Range (ATR) 2.96 0.17
MACD 0.08 -0.03
Stochastic Oscillator 50.82 41.74

Price Performance

Historical Comparison
PTCT
IEP

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About IEP Icahn Enterprises L.P.

Icahn Enterprises LP provides diversified business services in the United States. The company operates its business through varied segments which include Investment, Automotive, Energy, Food Packaging, Real Estate, Pharma, and Home Fashion. Among these, the Energy segment derives the maximum revenue from the company. Geographically, it generates maximum revenue from the United States.

Share on Social Networks: